News: Blood

FERM Target for Rare Leukemia

Friday, November 18th, 2011

Most patients diagnosed with adult T-cell leukemia/lymphoma (ATLL) – a rare, aggressive blood cancer – will die within a year of diagnosis. No currently available treatments alter the disease’s aggressive clinical course. Utpal Davé, M.D., and colleagues are working to identify genes and pathways that drive or initiate ATLL. In the Oct. 6 issue of […]